Edwards Lifesciences | EW - Selling And Administration Expenses


Edwards Lifesciences reported $560.9M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 82.88M 319K Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Globus Medical USD 288.47M 1.65M Sep/2026
ICU Medical USD 154.41M 2.48M Sep/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 113.94M 2.3M Sep/2026
Teleflex USD 220.72M 7.21M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026